T1	Participants 100 133	bleeding from esophageal varices.
T2	Participants 193 295	bleeding esophageal varices in patients who did not respond to blood transfusion and vasoactive drugs.
T3	Participants 317 389	101 patients with cirrhosis of the liver and bleeding esophageal varices
